Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 218 participants.
Also called NCT04275219
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 218 participants
- Sponsor
- Registry
-
NCT04275219
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04275219. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-15 (actual); primary completion 2021-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia
- Acronym
- TFXSHF
- Condition
- Stroke
- Condition
- Complication
- Intervention (Drug)
- Tongfu capsules
- Intervention (Drug)
- The Placebo of Tongfu capsules
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
- Collaborator
- People's Hospital of Ganzhou City
- Collaborator
- People's Hospital of Lianjiang City
- Collaborator
- Yangjiang Hospital of Traditional Chinese Medicine
- Collaborator
- Shenyang No. 2 Hospital of Traditional Chinese Medicine
- Collaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct04275219- Content hash
65ea97165524396b8e362509d83616f76f8b37f104f6598959226e25bf525177